The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2013

Filed:

Oct. 29, 2010
Applicants:

Karol L. Nowakowski, Circle Pines, MN (US);

James E. Olson, Eagan, MN (US);

Edward T. Joseph, Inver Grove Heights, MN (US);

Daniel G. Ericson, Rochester, MN (US);

Inventors:

Karol L. Nowakowski, Circle Pines, MN (US);

James E. Olson, Eagan, MN (US);

Edward T. Joseph, Inver Grove Heights, MN (US);

Daniel G. Ericson, Rochester, MN (US);

Assignee:

Closys Corporation, St. Paul, MN (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61M 31/00 (2006.01); A61B 19/00 (2006.01); A61K 31/74 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
Abstract

A wound closure apparatus and associated methods are provided which utilize blood fluid by activating the clotting cascade of blood fluid within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. An apparatus for providing ways of inhibiting anticoagulating agents and slowing fibrin clot degradation are also disclosed. Kits are also disclosed. The invention provides a clotting cascade initiation apparatus including a substantially enclosed sterile containment chamber within which an aliquot of blood fluid, either autologous or from donor sources, can be received and retained. In preferred embodiments, the sterile containment chamber further includes a heparin binding agent which will bind heparin and remove it from the blood fluid. In further embodiments, the containment chamber will also include a procoagulating agent, wherein a clotting cascade can be initiated when the blood fluid is accepted into the sterile containment chamber.


Find Patent Forward Citations

Loading…